Heron Therapeutics | HRTX - Betriebsergebnis





Betriebsergebnis Veränderung Datum
ALKERMES USD -48.28M 37.33M 2026-03
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Amarin USD -2.26M 564K 2025-12
ANI Pharmaceuticals USD 38.71M 9.58M 2026-03
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -141.26M 182.07M 2026-03
Eisai JPY -10.31B 30.35B 2026-03
Emergent BioSolutions USD -218M 69.9M 2023-06
Esperion Therapeutics USD 85.23M 95.19M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -200.28M 49.43M 2026-03
Ligand Pharmaceuticals USD 60.33M 40.29M 2026-03
Merck USD -1.88B 8.12B 2026-03
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Neurocrine Biosciences USD 214.6M 13.3M 2026-03
Omeros USD -35.41M 23.75M 2024-09
Pacira USD 4.62M 1.43M 2026-03
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Surmodics USD 58K 5.7M 2025-06
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
Veracyte USD 19.08M 5.55M 2026-03
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03